Advanced Medical Technology Assn

Based in DC

🤖

AI Overview

With $26.5M in lobbying spend across 33 quarterly filings, Advanced Medical Technology Assn is one of the biggest lobbying spenders in Washington. They deploy 13 individual lobbyists Their lobbying covers 7 issue areas. Active from 2018 to 2025.

$26.5M
Total Spend
8
Years Active
1
Firms Hired
13
Lobbyists Deployed
7
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2018$3.0M
2019$3.9M
2020$4.0M
2021$2.3M
2022$2.8M
2023$2.9M
2024$3.8M
2025$3.8M

Issues Lobbied

Lobbying Firms

Lobbyists

Government Agencies Targeted

These are the government entities that Advanced Medical Technology Assn disclosed contacting in their lobbying filings.

HOUSE OF REPRESENTATIVESSENATEEnvironmental Protection Agency (EPA)Food & Drug Administration (FDA)Health & Human Services, Dept of (HHS)Federal Emergency Management Agency (FEMA)Centers For Disease Control & Prevention (CDC)White House OfficeCenters For Medicare and Medicaid Services (CMS)Commerce, Dept of (DOC)U.S. Trade Representative (USTR)Natl Security Council (NSC)State, Dept of (DOS)Office of Management & Budget (OMB)Treasury, Dept of
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Budget/Appropriations, Trade, Transportation, Taxation, Health Issues and 2 more

Issues related to funding for the Food and Drug Administration

H.R. 1625 - vehicle for the Consolidated Appropriations Act of 2018

Issues related to price caps for medical technology in India

Issues related to modernization of the Committee for Foreign Investment in the United States (CFIUS)

Issues related to tariffs on medic

S. 1405 and H.R. 2997 Issues related to the air transport of lithium batteries

H.R. 184, S. 108 bills related to the Medical Device Excise Tax

H.R. 195 - continuing resolution through February 8, 2018 and related provisions

Issues related to the reform of the tax code and ta

Issues related to implementation of PL 115-52, the Food and Drug Administration Reauthorization Act

Issues related to implementation of the 21st Century Cures Act

Issues related to the competitive

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.